Celldex Therapeutics (CLDX) Q4 2022 Earnings

9NovConfirmed
Q1 2022
Q2 2022
Q3 2022
Q4 2022
-0.59
-0.53
-0.48
-0.42

Details

Expected EPS
-0.57
Actual EPS
-0.57
Surprise EPS
0
Surprise Percent
+0%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.57 per share for Q4 2022.

0 Comments

Share your thoughts